Author： Sontheimer Harald Bridges Richard J
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.5, 2012-05, pp. : 575-578
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Therapeutic nanomedicine for brain cancer
By Tzeng Stephany Y Green Jordan J
Therapeutic Delivery, Vol. 4, Iss. 6, 2013-06 ,pp. :
Access to resources
Recommend
The economics of temozolomide in brain cancer
By Crott Ralph
Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. :
Sulfasalazine: Encephalopathy: case report
Reactions Weekly, Vol. 1, Iss. 1232, 2008-01 ,pp. :
No significant teratogenic risk with sulfasalazine
Inpharma, Vol. 1, Iss. 1288, 2001-01 ,pp. :
Sulfasalazine: Pericarditis: case report
Reactions Weekly, Vol. 1, Iss. 1179, 2007-01 ,pp. :